Arlington Heights School District 25 “utterly failed to support medically vulnerable children by allowing a school nurse to ...

The FDA has accepted for review the sBLA for fremanezumab-vfrm for the prevention of episodic migraine in pediatric patients aged 6 to-17 years weighing at least 45 kg.

Dextenza is an intracanalicular insert that delivers a 0.4mg dose of dexamethasone, a corticosteroid, for up to 30 days following insertion.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...